Nephron Pharmaceuticals Corp nephronpharm.com


Nephron Pharmaceuticals Corporation is a privately owned manufacturer of generic inhalation solutions headquartered in Orlando, FL. Nephron specializes in blow-fill-seal (BFS) manufacturing, a technology that allows a vial of medication to be formed, filled and sealed in a continuous process without human intervention in a sterile, enclosed area.

Nephron Pharmaceuticals Corporation is a privately owned manufacturer of generic inhalation solutions headquartered in Orlando, FL. Nephron specializes in blow-fill-seal (BFS) manufacturing, a technology that allows a vial of medication to be formed,...Show all

Company (Alive / Active)

Phone: 800-443-3414

Fax:

4121 SW 34th Street

Orlando, 32811
Florida, United States

Latest News

See more competitors data Competitors
Total Funding Date of Last Funding
Nephron Pharmaceuticals Corp $75M Aug 21, 2014

Web Traffic

Rank

Show (-10)

Engagement (PVPU)

Show (+1%)

Domain Authority Score
Show
Page Views Per Million (PVPM)
Show
Reach Per Million
Show

SEO Statistics

Domain Authority Score Show
Page Authority Score Show
No. External Links Show
No. Links Show

Web Traffic Statistics - Growth

Per Week Per Month Per 6 Months Per Year
Rank Login to see details
Page Views Per Million Login to see details
Page Views Per User Login to see details
Reach Per Million Login to see details

Related Nephron Pharmaceuticals Corp Jobs

jobs by Indeed job
						search

Investors

Investor Investor Type Location Participating Rounds
Undisclosed InvestorsOther
Kayne Anderson Mezzanine PartnersDebt & Specialty FinanceNew York, New York, United StatesDebt
See all 2 investors
There is no Board of Directors data available for this company. Please select another tab.
There is no Competitors data available for this company. Please select another tab.

Patents

Title Application Date Patent Date Status
(Patent / Application)
Container for liquid May 11, 2012 Jun 09, 2015 Patent
Budesonide formulation Jan 16, 2015 Application
Formulation Aug 27, 2014 Application
Formulation of olopatadine Aug 27, 2014 Application